BioPharma Resources

Drug Trial Radar · NCT07705607

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 1,104 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,104

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Nov 30, 2028

Study completion Nov 30, 2029

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
Jul 15, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for every person. The main goal of this trial is to learn if MK-8748 works as well as aflibercept to treat DME.

Conditions

  • Diabetic Retinopathy
  • Macular Edema

Interventions

  • MK-8748Drug

    Administered by intravitreal injection (IVT)

  • AfliberceptDrug

    Administered by intravitreal injection (IVT)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Best-Corrected Visual Acuity (BCVA) (Early Treatment of Diabetic Retinopathy Study [ETDRS] Letters) From Baseline to Year 1Time frame: Baseline and 1 Year

Locations

31 sites in 4 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants, Ltd ( Site 0082)

    Phoenix, Arizona · Recruiting

  • California Retina Consultants ( Site 0023)

    Bakersfield, California · Recruiting

  • Retina-Vitreous Associates Medical Group ( Site 0124)

    Beverly Hills, California · Recruiting

  • South Coast Retina Center ( Site 0121)

    Long Beach, California · Recruiting

  • Retinal Consultants Medical Group ( Site 0017)

    Modesto, California · Recruiting

  • Retinal Consultants Medical Group ( Site 0015)

    Sacramento, California · Recruiting

  • Retina Group of New England ( Site 0101)

    Waterford, Connecticut · Recruiting

  • Florida Retina Institute ( Site 0035)

    Orlando, Florida · Recruiting

  • Retina Vitreous Associates of Florida ( Site 0036)

    St. Petersburg, Florida · Recruiting

  • Center for Retina and Macular Disease ( Site 0047)

    Winter Haven, Florida · Recruiting

  • Associated Vitreoretinal and Uveitis Consultants ( Site 0099)

    Carmel, Indiana · Recruiting

  • Wolfe Eye Clinic ( Site 0044)

    West Des Moines, Iowa · Recruiting

  • Cumberland Valley Retina Consultants ( Site 0003)

    Hagerstown, Maryland · Recruiting

  • Retina-Vitreous Surgeons of Central NY ( Site 0021)

    Liverpool, New York · Recruiting

  • North Carolina Retina Associates ( Site 0122)

    Greenville, North Carolina · Recruiting

  • Graystone Eye ( Site 0059)

    Hickory, North Carolina · Recruiting

  • Piedmont Retina Specialists ( Site 0049)

    Winston-Salem, North Carolina · Recruiting

  • Palmetto Retina Center ( Site 0073)

    Aiken, South Carolina · Recruiting

  • Charleston Neuroscience Institute ( Site 0090)

    Beaufort, South Carolina · Recruiting

  • Charleston Neuroscience Institute ( Site 0076)

    Charleston, South Carolina · Recruiting

  • Retina Consultants of South Carolina ( Site 0026)

    Ladson, South Carolina · Recruiting

  • Texas Retina ( Site 0051)

    Arlington, Texas · Recruiting

  • Texas Retina Associates ( Site 0055)

    Fort Worth, Texas · Recruiting

  • Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100)

    Katy, Texas · Recruiting

  • Retina Consultants of Texas ( Site 0005)

    San Antonio, Texas · Recruiting

  • Retina Center of Texas ( Site 0096)

    Southlake, Texas · Recruiting

  • Centro de Ojos Dr. Rodrigo Santos (RSResearch SRL) ( Site 0408)

    CABA, Argentina · Recruiting

  • Centro Privado de Ojos Romagosa ( Site 0407)

    Córdoba, Argentina · Recruiting

  • Instituto de Microcirugia Ocular Cordoba ( Site 0405)

    Córdoba, Argentina · Recruiting

  • Yitzhak Shamir Medical Center. ( Site 0723)

    Tsrifin, Israel · Recruiting

  • Emanuelli Research & Development Center LLC ( Site 0300)

    Arecibo, Puerto Rico · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.